Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MDLN · against 1,336 other Healthcare companies
Ranked #209 of 1,337 · scores higher than 84% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 80–89, including MDLN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | MDLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 2.3% | 1.5% | 56% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 5.3% | 4.2% | 57% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | Not reported | -1.0% | — | — | 20% |
| Book yieldHigher is better · 1,306 reported | 38.7% | 37.9% | 51% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 209 | 19.7B HKD (≈$2.5B) | 84 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 84 |
| 209 | 1.9B EUR (≈$2.1B) | 84 | 52 |
| 209 | 921.9B INR (≈$11.1B) | 84 | 82 |
| 209 | 353M EUR (≈$388M) | 84 | 77 |
| 209 | 45.9B USD | 84 | 61 |
| 209 | 1.5B USD | 84 | 65 |
| 209 | 9.7B AUD (≈$6.4B) | 84 | 52 |
| 209 | 18.7B THB (≈$525M) | 84 | 55 |
| 222 | 250.4B KRW (≈$180M) | 83 | 60 |